Lexology January 23, 2018
Ropes & Gray LLP

On Tuesday, January 23, Ropes & Gray hosted a teleconference on the regulatory and compliance impact of the Trump Administration’s first year on life sciences and health care companies. The discussion featured the perspectives of life sciences partners Greg Levine, Kellie Combs, Al Cacozza, health care partner Tom Bulleit and government enforcement partner Colleen Conry. The call examined various issues, including:

  • Impact of new...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ACA (Affordable Care Act), Biotechnology, CMS, Congress / White House, Cures Act, FDA, Healthcare System, HHS, Regulations, Value Based
What to know about Trump's surgeon general nominee
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Trump's pick for CDC director: 10 things to know
Trump tariffs could drive up generic drug costs: 5 takeaways
Senators urge Congress to avert Medicare physician pay cut

Share This Article